37 results match your criteria: "Kitasaito Hospital[Affiliation]"
Int J Urol
January 2025
Department of Urology, Wakayama Medical University, Wakayama, Japan.
We performed a systematic review and meta-analysis to evaluate the benefits and harms of pharmacotherapies for patients with calcium oxalate stones and abnormal urine chemistry. This article is a modified and detailed version of the commentary on Clinical Question 10 described in the Japanese Clinical Practice Guidelines for the Management of Urinary Stones, Third Edition. PubMed and Ichushi Web were searched through August 2020 for articles on pharmacotherapies for calcium oxalate stones (thiazides, citrate preparations, uric acid production inhibitors, and magnesium preparations).
View Article and Find Full Text PDFAm J Nephrol
December 2024
Committee of Renal Data Registry, Japanese Society for Dialysis Therapy, Tokyo, Japan.
Introduction: The optimal time for vascular access (VA) creation remains controversial.
Methods: We conducted a cohort study using data from the Japanese Society for Dialysis Therapy Renal Data Registry. Adult patients who started receiving hemodialysis in 2007 and had a permanent VA created were included.
Int J Urol
September 2024
Urology Department, Kitasaito Hospital, Asahikawa, Hokkaido, Japan.
Objective: Transvaginal mesh surgery for pelvic organ prolapse has been widely performed in Japan, but polypropylene mesh has not been used in Japan since the ban on TVM using polypropylene mesh in the United States. Currently, polytetrafluoroethylene mesh ORIHIME® is the only mesh available for TVM in Japan. Although polytetrafluoroethylene is a safe material, its low coefficient of friction and insufficient adhesion to the surrounding tissue make it difficult to maintain the mesh position when it is used in the transvaginal mesh surgery.
View Article and Find Full Text PDFSci Rep
May 2024
Committee of Renal Data Registry, Japanese Society for Dialysis Therapy, Tokyo, Japan.
Dialyzers are classified into five types based on their β-microglobulin clearance rate and albumin sieving coefficient: Ia, Ib, IIa, and IIb. In addition, a new classification system introduced a type S dialyzer. However, limited information is available regarding the impact of dialyzer type on patient outcomes.
View Article and Find Full Text PDFWorld J Urol
March 2024
Department of Renal and Urologic Surgery, Asahikawa Medical University, 2-1-1-1 Midorigaoka Higashi, Asahikawa, 078-8510, Japan.
Purpose: To compare the efficacy and safety of mirabegron and vibegron in female OAB patients.
Methods: We conducted a multicenter, prospective, randomized crossover study of female patients with OAB. The patients were assigned to Group MV (mirabegron for 8 weeks, followed by vibegron for 8 weeks) or group VM (vibegron for 8 weeks, followed by mirabegron for 8 weeks).
Clin Pharmacol Drug Dev
January 2024
Department of Urology, Urinary Stone Medical Center, Kitasaito Hospital, Asahikawa, Hokkaido, Japan.
Dotinurad has been approved in Japan as a selective urate reabsorption inhibitor for the treatment of gout and hyperuricemia. The relationship between uric acid crystallization and the use of uricosuric drugs is widely acknowledged; however, the relationship between changes in urinary uric acid concentration and urine pH or volume has not been sufficiently analyzed. Therefore, we investigated the changes in urinary uric acid concentration following dotinurad administration as well as the relationship between urine pH or volume and urinary uric acid concentration.
View Article and Find Full Text PDFAm J Nephrol
July 2023
Committee of Renal Data Registry, Japanese Society for Dialysis Therapy, Tokyo, Japan.
Introduction: Vascular access usage varies widely across countries. Previous studies have evaluated the association of clinical outcomes with the three types of vascular access, namely, arteriovenous fistula (AVF), arteriovenous graft (AVG), and tunneled and cuffed central venous catheter (TC-CVC). However, little is known regarding the association between arterial superficialization (AS) and the mortality of patients.
View Article and Find Full Text PDFNephrol Dial Transplant
May 2023
The Committee of Renal Data Registry, the Japanese Society for Dialysis Therapy, Tokyo, Japan.
Background: Hemoglobin A1c (A1c) and glycated albumin (GA) are two blood glycated proteins commonly used to monitor glycemic control in dialysis patients with diabetes. However, little is known about the association between the GA/A1c ratio and mortality in these populations. Here, we examine these associations using a nationwide cohort.
View Article and Find Full Text PDFJ Clin Endocrinol Metab
June 2022
Division of Nephrology, Endocrinology and Metabolism, Tokai University School of Medicine, Isehara, Japan.
Context: Parathyroidectomy (PTx) and cinacalcet are both effective treatments for secondary hyperparathyroidism in hemodialysis patients, but limited data exist comparing the long-term outcomes of these interventions.
Objective: We aimed to compare the risk of mortality among hemodialysis patients who underwent PTx and those who started treatment with cinacalcet.
Methods: In this prospective cohort study, comprising patients from the Japanese Society for Dialysis Therapy Renal Data Registry, patients who had intact parathyroid hormone (PTH) levels ≥ 300 pg/mL in late 2007 and underwent PTx or started treatment with cinacalcet in 2008 to 2009 were matched by propensity score at 1:3.
Sci Rep
October 2021
The Committee of Renal Data Registry, Japanese Society for Dialysis Therapy, Tokyo, Japan.
A target Kt/V of > 1.4 and use of a high-flux dialyzer are recommended for patients on hemodialysis. However, there is little information on the relationship between the dialyzer surface area and mortality in these patients.
View Article and Find Full Text PDFPerit Dial Int
March 2022
Kidney Center, Department of Medicine, Tokyo Women's Medical University, Japan.
Background: The use of exchange devices for peritoneal dialysis (PD) fluids is a common practice in Japan. Evidence on the effectiveness of exchange devices in preventing PD-related peritonitis is scarce. We evaluated the association between the use of exchange devices for PD fluids and peritonitis incidence.
View Article and Find Full Text PDFFront Med (Lausanne)
August 2021
The Committee of Renal Data Registry, Japanese Society for Dialysis Therapy, Tokyo, Japan.
Dialyzers are classified as low-flux, high-flux, and protein-leaking membrane dialyzers internationally and as types I, II, III, IV, and V based on β-microglobulin clearance rate in Japan. Type I dialyzers correspond to low-flux membrane dialyzers, types II and III to high-flux membrane dialyzers, and types IV and V to protein-leaking membrane dialyzers. Here we aimed to clarify the association of dialyzer type with mortality.
View Article and Find Full Text PDFSci Rep
June 2021
The Committee of Renal Data Registry, The Japanese Society for Dialysis Therapy, Tokyo, Japan.
Few data are available regarding the association of dialyzer type with prognosis. In Japan, dialyzers are classified as types I, II, III, IV, and V based on β-microglobulin clearance rates of < 10, < 30, < 50, < 70, and ≥ 70 mL/min, respectively. We investigated the relationship of the 5 dialyzer types with 1-year mortality.
View Article and Find Full Text PDFJ Nephrol
April 2021
Department of Nephrology, National Hospital Organization Chibahigashi National Hospital, 673 Nitona-cho, Chuo-ku, Chiba, 260-8712, Japan.
Background: Although a substantial number of patients return to dialysis after kidney transplant failure, it remains controversial whether transplant-failure patients have a higher mortality risk than transplant-naïve patients on dialysis who have never undergone kidney transplantation. We compared outcomes of transplant-failure and transplant-naïve patients on hemodialysis.
Methods: Data from the Japanese National Dialysis Registry (2012-2013) were analyzed, including 220,438 prevalent hemodialysis patients.
Curr Urol
October 2020
Department of Urology, Kitasaito Hospital, Asahikawa.
Introduction: There have been a number of reports on dose increase therapy (DI-T) with the alpha 1 adrenoceptor antagonists (α1-blockers) naftopidil and tamsulosin for lower urinary tract symptoms associated with benign prostatic hyperplasia.
Methods And Results: The reports on DI-T (naftopidil 75 mg/d, tamsulosin 0.4 mg/d) in non-responders to low-dose initial therapy (LI-T, naftopidil 50 mg/d, tamsulosin 0.
BMJ Open Diabetes Res Care
October 2020
Committee of Renal Data Registry, Japanese Society for Dialysis Therapy, Tokyo, Japan.
Introduction: Differences in mortality and cause-specific mortality rates according to glycated albumin (GA) and hemoglobin A1c (HbA1c) levels among dialysis patients with diabetes based on hypoglycemic agent use and malnutrition status remain unclear. Here, we examine these associations using a nationwide cohort.
Research Design And Methods: We examined 40 417 dialysis patients with diabetes who met our inclusion criteria (female, 30.
Hinyokika Kiyo
July 2020
The Department of Renal and Urologic Surgery, Asahikawa Medical University.
We present 2 cases of penile cancer in which the inguinal lymph node was not palpable and inguinal lymph node dissection (ILND) could be safely avoided by conducting dynamic sentinel lymph node biopsy (DSNB). The first case was in a 54-year-old man complaining of penile tumor for at least 3 months. We performed partial penectomy and DSNB.
View Article and Find Full Text PDFHinyokika Kiyo
February 2020
The Department of Renal and Urologic Surgery, Asahikawa Medical University.
Psoas muscle mass index (PMI) is related to sarcopenia. We examined whether PMI is associated with early complications after radical cystectomy. Seventy one male and 29 female patients who were 65 years old or older and who had undergone radical cystectomy at our hospital from April 2005 to March 2018 were retrospectively analyzed.
View Article and Find Full Text PDFNihon Hoshasen Gijutsu Gakkai Zasshi
December 2019
Faculty of Health Sciences, Hokkaido University.
Appropriate information security measures are very important for today's highly computerized hospitals to maintain the trust from patients. If once the personal information leakage of medical information was occurred, the hospital could lose their trust that has built for long time so far. It is important for hospitals to know the impact of the leakage accident previously advance to decide the investment for information security.
View Article and Find Full Text PDFClinicoecon Outcomes Res
September 2019
Artificial Organs and Surgery, Tsuchiya General Hospital, Hiroshima City, Hiroshima, Japan.
Background: In Japan, the medical expenditures associated with dialysis have garnered considerable interest; however, a cost-effectiveness evaluation of peritoneal dialysis (PD) is yet to be evaluated. In particular, the health economics of the "PD first" concept, which can be advantageous for clinical practice and healthcare systems, must be evaluated.
Methods: This multicenter study investigated the cost-effectiveness of PD.
Sci Rep
March 2019
The Committee of Renal Data Registry, the Japanese Society for Dialysis Therapy, Tokyo, Japan.
There has been no nationwide study of prognostic factors and outcomes in patients on peritoneal dialysis (PD) in Japan. We conducted a cohort study using data from the nationwide registry of the Japanese Society for Dialysis Therapy. We followed 8,954 prevalent PD patients for 2 years, 2014-2015.
View Article and Find Full Text PDFSci Rep
March 2019
The Committee of Renal Data Registry, Japanese Society for Dialysis Therapy, Tokyo, Japan.
For glycemic control in patients with diabetes on peritoneal dialysis (PD), the level of glycated albumin (GA) associated with mortality is unclear. Accordingly, we examined the difference in the association of GA and glycated hemoglobin (HbA1c) with 2-year mortality in a Japanese Society for Dialysis Therapy cohort. We examined 1601 patients with prevalent diabetes who were on PD.
View Article and Find Full Text PDFHum Cell
April 2019
Department of Integrative Physiology and Bio-Nano Medicine, National Defense Medical College, 3-2 Namiki, Tokorozawa, Saitama, 359-8513, Japan.
Renal hypouricemia (RHUC) is a disease caused by dysfunction of renal urate reabsorption transporters; however, diagnostic guidance and guidelines for RHUC have been lacking, partly due to the low evidence level of studies on RHUC. This review describes a world-first clinical practice guideline (CPG) and its first version in English for this condition. It was developed following the "MINDS Manual for Guideline Development" methodology, which prioritizes evidence-based medicine.
View Article and Find Full Text PDFKidney Int
April 2019
Renal Data Registry Committee, Japanese Society for Dialysis Therapy, Tokyo, Japan; Yabuki Hospital, Yamagata, Japan.
On-line hemodiafiltration is an increasingly common alternative to chronic hemodialysis in some countries, based on the results of randomized controlled trials of post-dilution on-line hemodiafiltration. There are now more than 60,000 patients treated with on-line hemodialfiltration in Japan, over 95% of whom use predilution on-line hemodiafiltration; however, large-scale data on clinical outcomes with this modality are lacking. We created a propensity-matched cohort of 5,000 pairs of patients treated with conventional hemodialysis or predilution on-line hemodiafiltration, using the Japanese Society for Dialysis Therapy Renal Data Registry database from December 31, 2012 to December 31, 2013.
View Article and Find Full Text PDFJ Glob Oncol
September 2018
Ulrike Schaede, University of California at San Diego, San Diego, CA; Jörg Mahlich, Janssen Pharmaceutical K.K., Tokyo, Japan, and University of Düsseldorf, Düsseldorf, Germany; Masahiko Nakayama, Hisanori Kobayashi, and Kazutake Yoshizawa, Janssen Pharmaceutical K.K.; Yuriko Takahashi and Katsuhiko Saito, Anterio, Tokyo; Hiroji Uemura, Yokohama City University, Medical Center, Yokohama; and Masayuki Tokumitsu, Kitasaito Hospital, Ashikawa, Japan.
This article adds the Japanese perspective to our knowledge of shared decision-making (SDM) preferences by surveying patients with prostate cancer (PCA) and physicians in Japan. In 2015, 103 Japanese patients with PCA were asked about their SDM preferences by using an Internet-based 5-point-scale questionnaire. Concurrently, 127 Japanese physicians were surveyed regarding their perceptions of patient preferences on SDM.
View Article and Find Full Text PDF